Equatorin (MN9 antigenic molecule) is a widely distributed acrosomal protein in mammalian sperm. During the acrosome reaction, some amount of equatorin translocates to the plasma membrane, covering the equatorial region. From the results of studies of both in vitro and in vivo fertilization inhibition using the MN9 antibody, equatorin has been suggested to be involved in fusion with the oolemma. In the present study, we cloned equatorin and, using mass spectrometry and carbohydrate staining, found it to be a highly glycosylated protein. Equatorin is a sperm-specific type 1 transmembrane protein, and glycosidase treatment and recombinant protein assays verified that it is an N,O-sialoglycoprotein. In addition, the gamete interactionrelated domain recognized by the MN9 antibody is posttranslationally modified. The modified domain was identified near threonine 138, which was most likely to be O-glycosylated when analyzed by amino acid substitution, dephosphorylation, and Oglycosylation inhibitor assays. Immunogold electron microscopy localized the equatorin N-terminus, where the MN9 epitope is present, on the acrosomal membrane facing the acrosomal lumen. These biochemical properties and the localization of equatorin are important for further analysis of the translocation mechanism leading to gamete interaction. fertilization, gamete biology, gamete interaction, MN9/equatorin, sperm
INTRODUCTION
Among the few molecules known to be vital for sperm-egg fusion are sperm Izumo1 [1] and egg CD9 [2] [3] [4] . Izumo1 is a type 1 transmembrane protein localized to the acrosome before the acrosome reaction, and it relocates onto the sperm surface after the acrosome reaction [1] . The details of the molecular mechanisms involved in this process remain unclear. A tetraspanin molecule, CD9 is expressed on the oolemma, but the nature of the CD9-sperm ligand interaction remains unclear. Several other gamete fusion candidate molecules have been identified. However, gene deletion studies have shown that they are not essential in sperm-egg fusion, although their roles may be substituted or bypassed by other proteins. These molecules include ADAMs 1, 2, and 3-also known as fertilina, fertilin-b, and cyritestin, respectively [5] [6] [7] [8] -in addition to CRISP1 (DE) [9] and CD46 [10] . Other candidate molecules required for sperm-egg fusion have been reported, and their functions have been studied by specific antibody inhibition assays. These include equatorin (EQT)-also known as MN9 antigen [11, 12] -SPESP1 (ESP) [13, 14] , SPACA4 (SAMP14) [15] , SPACA1 (SAMP32) [16] , and SPACA3 (SLLP1) [17] . Thus, the molecular mechanisms underlying sperm-egg fusion remain an open question. (Equatorin [EQT] is not official; the nomenclature is being considered by the Mouse Genomic Nomenclature Committee and the HUGO Gene Nomenclature Committee.)
Some of the major difficulties in analyzing the molecular mechanisms underlying sperm-egg fusion include the biochemical nature and localization of the sperm proteins. In fact, sperm glycoproteins have unique carbohydrate chains and show continuous modifications after spermiation until the sperm-egg interaction [18] [19] [20] [21] [22] . In addition, the localization of some sperm proteins changes during the acrosome reaction, as seen with equatorin [23] , Izumo1 [1] , and SPACA4 [15] ; these molecules are translocated from the acrosomal matrix to the cell surface. These modifications are thought to be important steps, priming sperm molecules for the sperm-egg interaction.
We previously reported that the MN9 antigen equatorin was widely distributed in mammals, including humans, and showed a strong affinity for the equatorial region of the acrosome [24] ; thus, the MN9 antigen was renamed equatorin. Functionally, the anti-equatorin antibody MN9 inhibits the release of cortical granules without inhibiting zona penetration and sperm-egg binding, suggesting that it inhibits sperm-egg fusion or an early stage of egg activation [11] . The MN9 antibody inhibits spermegg interaction not only in vitro but also in vivo [12] . During the acrosome reaction, equatorin translocates to the plasma membrane, covering the equatorial segment as seen with immunogold staining [23] . The plasma membrane over the equatorial segment is known to fuse with the plasma membrane of egg microvilli [25] [26] [27] [28] .
Based on these findings, the aim of the present study was to identify the equatorin gene and to clarify the biochemical nature and localization of the equatorin protein. In particular, we focused on the nature of the epitope region of the MN9 1 Supported by a grant from the Japan Society for the Promotion of Science to K. Toshimori (16390046 and 19591878) antibody (MN9 epitope), because this region is expected to be involved in the sperm-egg interaction.
MATERIALS AND METHODS

Animals and Reagents
Male ICR mice (age, 16 wk) were purchased from Charles River Japan and kept in an air-conditioned room (12L:12D, 248C) with free access to food and water. The present study was conducted according to the guidelines for the care and use of laboratory animals of the Chiba University Graduate School of Medicine.
A monoclonal antibody, MN9 (IgG2a), which specifically recognizes equatorin, was produced in female BALB/c mice by immunizing them with cauda epididymal sperm from CD1 mice. Antibody production, purification, and characterization were reported previously [11, 12, 23, 24] . The EQ [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] antibody is a specific antibody newly raised against 14 amino acids of equatorin (residues 70-83) as described below.
General chemicals and antibodies used were as follows: horseradish peroxidase (HRP)-conjugated sheep anti-mouse IgG, HRP-conjugated donkey anti-rabbit IgG, and PY20 mouse anti-phosphotyrosine monoclonal antibody (GE Healthcare); Pro-Q Emerald 300 glycoprotein gel staining kit, SYPRO Ruby protein gel stain, rabbit anti-green fluorescent protein (GFP) antibody IgG fraction, Alexa Fluor 488 goat anti-mouse IgG, Alexa Fluor 546 goat antirabbit IgG, Alexa Fluor 555 donkey anti-mouse IgG, and Alexa Fluor 568 goat anti-rabbit IgG (Invitrogen); Hoechst 33258 and O-glycosylation inhibitor benzyl-2-acetamido-2-deoxy-a-D-galactopyranoside (Benzyl-a-GalNAc) [29] (Sigma Aldrich); and 5-and 10-nm colloidal gold-conjugated anti-mouse IgG (BBInternational). Total RNA was extracted using an RNeasy Protect Mini Kit (Qiagen Sciences). We synthesized cDNA by oligo(dt) priming using a Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics). The peptide:N-glycosidase F (PNGase F), calf intestinal alkaline phosphatase (CIAP; New England Biolabs), and neuraminidase (Arthrobacter ureafaciens; Marukin Bio) were used according to the manufacturer's instructions.
Western Blot Analysis
Western blot analysis was used to examine the distribution of equatorin in various tissues and to verify the expression of recombinant equatorin protein in HEK293T cells, dephosphorylation, deglycosylation, and amino acid substitution assays. The samples for these experiments were extracted with SDS sample buffer (50 mM Tris-HCl [pH 6.8], 2% SDS, 100 mM dithiothreitol [DTT], 10% [v/v] glycerol, and 0.002% [w/v] bromophenol blue). The lysates were heated for 10 min at 988C and centrifuged at 16 000 3 g for 10 min to remove insoluble material. The lysates were then separated by SDS-PAGE and blotted onto a polyvinylidene difluoride membrane (PVDF; Millipore). Western blot analysis was performed according to a standard protocol using TBS-T (20 mM Tris-HCl [pH 7.6], 137 mM NaCl, and 0.1% [w/v] Tween 20) containing 5% (w/v) skimmed milk as blocking solution and for antibody dilution. Antibody concentrations used for Western blot analysis were as follows: MN9 antibody at 1:4000 (;0.1 lg/ml), EQ 70-83 antibody at 0.3 lg/ml, anti-GFP antibody at 1 lg/ml, and HRP-conjugated secondary antibodies at 1:10 000. The blots were developed with ECL Plus Western Blotting Detection Reagents (GE Healthcare) and exposed to x-ray film.
Sample Preparation for Mass Spectrometry
) were removed from cauda epididymides and washed twice in PBS. The sperm were then suspended in 0.1% Triton X-100 in PBS with Complete Protease Inhibitors (Roche Diagnostics) and kept on ice for 10 min, then centrifuged at 290 3 g for 10 min. The precipitated sperm were extracted with SDS-ethylenediaminetetra-acetic acid (EDTA) solution (75 mM NaCl, 1% SDS, and 25 mM EDTA [pH 6.0]) containing Complete Protease Inhibitors and centrifuged at 16 000 3 g for 10 min to remove insoluble debris. Liver was directly extracted with SDS-EDTA solution as a negative control. The SDS-EDTA solution extracts were precipitated with a 2D clean-up kit (GE Healthcare). The precipitated proteins were resuspended in NP-40 lysis buffer (150 mM NaCl, 1% NP-40, and 50 mM Tris-HCl [pH 8.0]). The lysates were precleared with Protein G Sepharose (GE Healthcare) for an hour at 48C and incubated with 10 lg of MN9 antibody overnight at 48C. Protein G Sepharose beads were added and incubated for an hour at 48C. The beads were washed three times with NP-40 lysis buffer and once with 50 mM Tris-HCl (pH 8.0). The beads were then suspended in SDS sample buffer and heated for 5 min at 988C to dissociate precipitates. After separation by SDS-PAGE, samples were detected using Pro-Q Emerald 300, SYPRO Ruby, and Western blot analysis with the MN9 antibody. The bands of interest were excised from a Pro-Q Emerald 300-stained gel. In-gel trypsin digestion and liquid chromatographytandem mass spectrometry (LC-MS/MS) were performed as reported previously [30] .
Alignment Analysis
A homologue search was done using the PSI-BLAST program [31] , and sequence alignment was achieved using the T-Coffee server [32, 33] . The signal peptide region was predicted using the SignalIP 3.0 server [34, 35] . The transmembrane domain was predicted using the TMHMM 2.0 server [36, 37] .
Antibody Production
Following the identification of equatorin as described in Results, an antiequatorin polyclonal antibody was produced and termed the EQ 70-83 antibody. Briefly, a rabbit was immunized with a synthetic, 14-residue, partial sequence of equatorin (GNYYKDIKQYVFTT) conjugated to the keyhole limpet hemocyanin. The EQ 70-83 antibody was then affinity purified using beads conjugated with the synthetic, 14-residue peptide and adjusted to the final concentration of 1.2 mg/ml. Because the EQ 70-83 and MN9 antibodies showed a similar staining pattern on Western blot and immunofluorescence (see Supplemental Fig. S2 , all Supplemental Data are available online at www.biolreprod.org), the EQ 70-83 antibody was considered to be verified as anti-equatorin antibody and used in the present study.
RT-PCR Analysis
To examine the expression of equatorin mRNA in various tissues, RT-PCR was performed. The specific primer pairs used were as follows: Eqt-forward,
0 -ACCACAGTCCATGCCATCAC-3 0 ; and Gapdh-reverse, 5 0 -TCCACCACCCTGTTGCTGTA-3 0 . The Gapdh primers were used as controls. Nucleotides from position 550 to 1011 of the equatorin long form were partially amplified. Twenty-five cycles of amplification were used, consisting of denaturation for 30 sec at 948C, annealing for 30 sec at 608C, and elongation for 30 sec at 728C.
Production of Recombinant Protein
HEK293T cells were purchased from the Riken Cell Bank and cultured in Dulbecco modified Eagle medium with 10% fetal bovine serum, 100 U/ml of penicillin, and 100 lg/ml of streptomycin at 378C with 5% CO 2 in air. Vectors were transfected using the FuGENE HD transfection reagent (Roche Diagnostics) as described in the manufacturer's manual. Briefly, cells were cultured for 24 h after transfection (48 h for the amino acid substitution study to obtain a high concentration), and cells washed with PBS were solubilized in SDS sample buffer for Western blot analyses. (Vector constructs are described in Vector Construction for Mouse Recombinant Equatorin.)
Indirect Immunofluorescence Microscopy for Testes and Epididymides
To examine the expression of equatorin in detail, indirect immunofluorescence (IIF) microscopy was performed with the MN9 and EQ 70-83 antibodies. Male ICR mice were anesthetized with Nembutal (Abbott Laboratories) and fixed with Bouin solution by perfusion through the left ventricle. Testes and epididymides were removed and immersed in the same fixative for an hour. After being dehydrated in a graded ethanol series and xylene, the samples were processed for paraffin embedding and sectioned (thickness, 2.5 lm). The sections were deparaffinized and autoclaved for 5 min at 1208C to activate the antigenicity. After 30 min in 0.1% Triton X-100 in PBS, nonspecific antibody binding was suppressed by incubation in blocking buffer (PBS containing 5% normal goat serum and 3% bovine serum albumin) for 30 min at room temperature. The sections were then incubated overnight with MN9 antibody (1:20 000 dilution, ;0.02 lg/ml) and EQ 70-83 antibody (0.6 lg/ml) at 48C and rinsed in PBS. The sections were then incubated with Alexa Fluor 488 goat anti-mouse IgG (0.5 lg/ml), Alexa Fluor 546 goat anti-rabbit IgG (0.5 lg/ml), and Hoechst 33258 (5 lg/ml) for 1 h at room temperature. Observations were made using an Olympus BX50 (Olympus Co.) microscope with a UPlanApo 403 NA 0.85 dry objective lens equipped with an imaging system composed of appropriate filters for fluorescence and a RETIGA Exi FAST 1394 CCD camera (Qimaging). Data acquisition and storage were controlled with SlideBook 4 software (Intelligent Imaging Innovations).
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Dephosphorylation of Equatorin by CIAP
Sperm removed from cauda epididymides were washed with PBS, extracted with SDS sample buffer, subjected to SDS-PAGE, and blotted onto a PVDF membrane. The PVDF membrane was incubated in NEB buffer 3 (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl, 2 mM DTT [pH 7.9], and EDTA-free Complete Mini Protease Inhibitors) with CIAP (20 U/ml) for 1 h at 378C, and the membrane was then subjected to immunostaining with the MN9 antibody to check the phosphorylation status of MN9 epitope or with the PY20 antiphosphotyrosine antibody (0.1 lg/ml) as a control to confirm dephosphorylation by CIAP treatment. Control (nondephosphorylated) samples were incubated without CIAP. The TBS-T containing 1% (w/v) bovine serum albumin was used for blocking solution.
PNGase F and Neuraminidase Treatment
Glycosidase treatments were performed basically according to the manufacturer's instructions (New England Biolabs) with slight modification: Neuraminidase was simultaneously added to the PNGase F treatment protocol. Sperm were removed from cauda epididymides (5 3 10 5 sperm suspended in 5 ll PBS/tube), washed with PBS, denatured and solubilized by adding 1 ll of denaturing buffer (5% SDS and 0.4 M DTT), and heated for 10 min at 988C. The samples were then neutralized by adding 2 ll of G7 buffer (0.5 M sodium phosphate, pH 7.5) and 2 ll of 10% NP-40 and centrifuged at 16 000 3 g to remove insoluble materials. Protease activity in the recovered supernatant was suppressed by adding Complete Protease Inhibitors and 1 lg/ml of pepstatin (Roche Diagnostics). PNGase F (125 U), neuraminidase from A. ureafaciens (0.05 U), or both were added to the supernatant and incubated for 12 h at 378C. The samples were then mixed with equal volumes of SDS sample buffer and subjected to Western blot analysis. The control samples were incubated without these glycosidases.
Inhibition of O-Glycosylation on Equatorin by Benzyl-a-GalNAc
HEK293T cells were supplemented with 0, 2, and 4 mM Benzyl-a-GalNAc before transfection of the pKSCX-Eqt(L)-EGFP vector. The cells were cultured for at least 24 h in the presence of Benzyl-a-GalNAc, then solubilized in SDS sample bufferandsubjectedtoWesternblotanalyses.Densitometryoftheimmunoblotswas done using ImageJ software (http://rsb.info.nih.gov/ij/index.html). The relative ratio of the immunostaining intensity of the MN9 antibody to that of the EQ 70-83 antibody (MN9/EQ 70-83 ) at 0 mM Benzyl-a-GalNAc was regarded as one. The relative ratios of MN9/EQ 70-83 at 2 and 4 mM Benzyl-a-GalNAc were then calculated, with the results shown in a bar graph. (Vector constructs are described in Vector Construction for Mouse Recombinant Equatorin.)
Determining Orientation of the Equatorin Epitope Region in the HEK293T Cell Plasma Membrane
To identify the MN9 epitope, the orientation of equatorin in the cell membrane was examined in HEK293T cells. Cells were cultured on a glass bottom dish (AGC Techno Glass Co., Ltd.) precoated with polyethyleneimine (Sigma Aldrich) and transfected with a C-terminally EGFP-tagged equatorin vector termed pKSCX-Eqt(L)-EGFP. The cells were cultured at least 24 h after the transfection and washed once with PBS. Thereafter, cells were fixed with 4% paraformaldehyde in PBS for 30 min. After washing twice in PBS, cells were incubated in PBS or permeabilized with 0.1% Triton X-100 for 10 min and then incubated with the MN9 antibody (1:40 000 dilution, ;0.01 lg/ml), the EQ 70-83 antibody (0.24 lg/ml), or an anti-GFP antibody (2 lg/ml) for 1 h at room temperature and rinsed with PBS. Cells were then incubated with Alexa Fluor 555 donkey anti-mouse IgG (0.5 lg/ml) or Alexa Fluor 568 goat antirabbit IgG (0.5 lg/ml) and Hoechst 33258 (5 lg/ml) in PBS for 1 h at room temperature. Cells were analyzed using an Olympus IX 71 (Olympus) microscope with a UPLSAPO 603 NA 1.2 water-immersion objective lens equipped with a CSU-XI confocal scanner (Yokogawa Electric Corporation). Three-dimensional projection images were captured using a QuantEM 512SC CCD camera (Photometrics) controlled by SlideBook 4 software.
Immunogold Electron Microscopy
After washing twice in TYH (Toyoda, Yoshida, and Hoshi) medium [38] , cauda epididymal sperm were frozen once at À808C and thawed before applying the primary antibody to permeabilize the membrane. The MN9 antibody was applied to the sperm for 1 h. The sperm were then incubated in a solution of colloidal gold-conjugated anti-mouse IgG (;1 lg/ml) for 1 h. After rinsing in the medium, sperm were fixed in 1% glutaraldehyde and postfixed in 2% osmium tetroxide solution. The fixed sperm were embedded in 2% agar, routinely dehydrated in an ethanol series, and embedded in Epon 812 (TAAB Laboratories Equipment). Ultrathin sections were routinely made using an ultramicrotome (Ultracut E; Reichert-Jung) and stained with lead and uranyl acetate for observation with a transmission-electron microscope (JEM-1200 EX; JEOL).
Vector Construction for Mouse Recombinant Equatorin
The FANTOM (Functional Annotation of Mouse) FLS clone (ID: 1700028B15 relevant to cloned mouse equatorin long form) was purchased -6) , whereas 2% of the amount was loaded for Western blot (lanes 1 and 2) . Lanes 1, 3, and 5: liver (negative control); lanes 2, 4, and 6: cauda epididymal sperm; lanes 1 and 2: Western blot with MN9 antibody; lanes 3 and 4: SYPRO Ruby staining: lanes 5 and 6: Pro-Q Emerald 300 staining. Equatorin focused on 40 kDa (lanes 2 and 6) .
from DNAFORM. The equatorin long form was inserted into pET-23a (Novagen) in frame with a C-terminal 6xHis-tag, designated as pET-23a-Eqt(L)-His, and used for Escherichia coli protein expression. The pET-23a-Eqt(L)-His vector was digested with BamHI and Bpu1102I. Fragments were blunt-ended by the Blunting high (Toyobo Co. Ltd.) and ligated into pKSCX-IRES (internal ribosome entry site)-EGFP, which was digested with EcoRV and treated with CIAP. This plasmid was named pKSCX-Eqt(L)-His and used for mammalian cell culture. An EGFP-tagged equatorin protein expression vector pKSCX-Eqt(L)-EGFP was created by deleting the His-tag and IRES with an inverse PCR mutagenesis method using the KOD Plus mutagenesis kit (Toyobo) starting from pKSCX-Eqt(L)-His according to the manufacturer's instructions using the appropriate primers (Supplemental Table S1 ). Vectors for the equatorin short form and equatorin mutant protein expression (partial deletion and single amino acid substitution) also were created using PCR-based mutagenesis (Supplemental Table S1 ). All vectors were verified by DNA sequencing.
RESULTS
Distribution of Equatorin in Various Tissues
To determine the distribution of equatorin in various tissues, we performed Western blot analysis with the MN9 antibody. Among the tissues examined, we found equatorin bands ranging from 40 to 65 kDa in testes (Fig. 1A, lane 12) and epididymides (Fig. 1A, lanes 13-15) . No bands were detected in other tissues (Fig. 1A, lanes 1-11) . Because no bands were detected by the MN9 antibody in liver samples (Fig. 1A, lane  5) , liver was used as a negative control for immunoprecipitation for LC-MS/MS analysis.
Identification of Equatorin and Analysis of the Amino Acid Sequence
Equatorin was purified by immunoprecipitation with the MN9 antibody. Purified equatorin was identified as a 40-kDa band (Fig. 1B and Supplemental Fig. S1 ). It is important to emphasize that equatorin, which was initially detected at 40 kDa by Western blot analysis (Fig. 1B, lane 2) , could not be detected by conventional staining methods, such as silver stain (our unpublished data) or SYPRO Ruby (Fig. 1B, lane 4) , but was detected by Pro-Q Emerald 300 staining (Fig. 1B, lane 6) . No bands were detected in the control liver sample (Fig. 1B,  lanes 1, 3, and 5) .
The 40-kDa band expected to be equatorin was excised and subjected to LC-MS/MS analysis. Mascot search results indicated a single significant candidate 4930579C15Rik (human orthologue has been reported to be frequently deleted in cancer [39] , and in vitro reverse genetic study has been reported [40] ). Based on the FANTOM full-length cDNA database of RIKEN (http://fantom.gsc.riken.go.jp), primers were designed for validation of the protein-coding region by sequencing cDNA prepared from the testes of an ICR mouse (GenBank/EMBL/DDBJ accession no. AB438105 for the long form and AB438106 for the short form). The data obtained were analyzed by amino acid sequence alignment for both human and mouse, based on a homologue search and domain search. The resulting peptide sequences are shown in Figure 2 . The molecular weight predicted from the amino acid sequence was 33 042 Da for short form of equatorin (296 amino acids) and 37 764 Da for long form (337 amino acids). A putative signal peptide region was found at the N-terminus at residues 1-20, and a transmembrane region was found at residues 186-208.
Based on the amino acid sequence alignment, oligopeptides ranging from residue 70 to residue 83, a highly conserved region in both humans and mice, were used to raise a specific antibody termed EQ 70-83 , which was used for further experiments in the present study.
Expression of Equatorin mRNA in Tissues
Next, we analyzed the mRNA expression of equatorin in various tissues by RT-PCR. Interestingly, two bands, both long and short forms, were present in testes (Fig. 3A, lane 11) . No   FIG. 2 . Amino acid sequence of equatorin identified by LC-MS/MS and alignment of human and mouse equatorin. Identical sequences in the alignment are shown with asterisks. The peptide sequences detected by LC-MS/MS are shown in boldface. The 14-amino-acid sequence, boxed region, was used to raise EQ 70-83 antibody. The putative signal peptide region is shaded, and the putative transmembrane domain is underscored.
892 band was detected in other tissues, including epididymides (Fig. 3A, lanes 1-10 and 12-14) .
Expression of Recombinant Equatorin in HEK293T Cells: Verification Study
To verify the identity of equatorin, we developed equatorin expression vectors for long, short, EGFP-tagged long, and EGFP-tagged short forms and transfected these equatorin vectors into HEK293T cells. Western blot analysis with the MN9 antibody detected recombinant equatorin. Both short and long forms were identified at 60-85 kDa (Fig. 3B, lanes 1 and  2) , whereas both EGFP-tagged short and long forms were detected as much higher bands at approximately 105 kDa (Fig.  3B, lanes 3 and 4) . Because the EGFP-tagged proteins were detected by the MN9 antibody as higher relative molecular mass bands than the untagged proteins, the cloned sequences were verified to be equatorin. The MN9 antibody did not recognize equatorin proteins expressed in E. coli (data not shown).
Distribution of Equatorin in Testes and Epididymides
Next, we determined the distribution of equatorin in detail using IIF microscopy with EQ 70-83 and MN9 antibodies. The epitopes of these antibodies are different: The EQ 70-83 antibody recognizes a small peptide region from residue 70 to residue 83 of equatorin, whereas the MN9 antibody recognizes the antigenic region that undergoes posttranslational modification (stated in Discussion). In agreement with the results of the Western blot study (Fig. 1A) , IIF microscopy showed that equatorin detected by the EQ 70-83 and MN9 antibodies was present in both the testes and epididymides, showing the same staining pattern, but not in epididymal epithelial cells. The protein was sperm specific, including germ cells (Fig. 3C) .
Phosphatase Treatment of Equatorin
Because we found that the MN9 antibody did not recognize equatorin proteins expressed in E. coli during the verification studies, the MN9 epitope was thought to be posttranslationally modified. We first examined the effect of dephosphorylation of the MN9 epitope using CIAP. However, immunostaining of the MN9 antibody remained after CIAP treatment, whereas that of the PY20 antibody decreased (Fig. 4A) , suggesting that the epitope of the MN9 antibody was not phosphorylated.
Evaluation of Equatorin Glycosylation by Mobility Shift Assays
Because equatorin was detected by Pro-Q Emerald glycoprotein staining, we treated cauda sperm extracts with PNGase F and neuraminidase to determine whether equatorin was glycosylated and whether N-glycosylation or the sialic acid moiety was involved in the epitope region of the MN9 antibody. The enzymatically treated samples were subjected to Western blot analysis with the MN9 antibody (Fig. 4B) . 
EQUATORIN: IDENTIFICATION OF THE EPITOPE OF THE MN9 ANTIBODY
PNGase F treatment reduced the molecular size of the two major bands of equatorin by approximately 2 kDa: The upper band went from 50 to 48 kDa, and the lower band went from 40 to 38 kDa (Fig. 4B, lanes 1 and 2) . In addition, the MN9 antibody recognized only a single, 27-kDa band after neuraminidase treatment (Fig. 4B, lanes 3 and 4) . Currently, whether this band is the long or short form is unclear. Thus, equatorin has an N-glycan with a sialylated O-glycan; i.e., it is a 40-to 50-kDa N,O-sialoglycoprotein. Interestingly, MN9 antigenicity was not eliminated by treatment with PNGase F and neuraminidase, suggesting that the MN9 epitope contains neither an N-linked carbohydrate nor a sialic acid moiety in the epitope region.
To assess the involvement of O-glycosylation in MN9 antigenicity, recombinant equatorin was expressed in HEK293T cells in the presence of the O-glycosylation inhibitor Benzyl-a-GalNAc. The relative ratio of MN9/EQ 70-83 decreased in a dose-dependent manner with increasing concentrations of the Benzyl-a-GalNAc inhibitor as shown in the bar graph (Fig. 4C) , suggesting the involvement of O-glycosylation in the MN9 epitope.
Determining Orientation of the Equatorin Epitope Region
The C-terminally EGFP-tagged equatorin was transfected into HEK293T cells, and the transfected cells were examined by IIF under antibody-nonpermeabilized or antibody-permeabilized conditions. Under nonpermeabilized conditions, both the EQ 70-83 antibody and MN9 antibody detected EGFPtagged equatorin (Fig. 5A, a-d) , whereas the anti-GFP antibody could not recognize EGFP-tagged equatorin (Fig.  5A, e and f) . Under permeabilized conditions, the anti-GFP antibody detected EGFP-tagged equatorin (Fig. 5A, g and h) .
Determining the Amino Acid Residue Bearing the Posttranslational Modification Essential for the MN9 Epitope
The results shown in Figure 5A suggest that equatorin is a type 1 transmembrane protein, with the MN9 epitope localized on the N-terminal side facing the external surface (Fig. 5A) . Therefore, to identify the exact amino acid position at which the posttranslational modification essential for MN9 epitope occurs, we first deleted a partial amino acid sequence (indicated by D) of equatorin, transfected this construct into HEK293T cells, and evaluated the immunostaining loss using Western blot analysis (Fig. 5B) . The MN9 antibody detected EQT(L)D21-50-EGFP and EQT(L)D31-100-EGFP but could not detect EQT(L)D31-146-EGFP (Fig. 5B, top) . The positive control anti-GFP antibody detected all samples (Fig. 5B, bottom) . The GFP bands that ran lower than the MN9 band were degradation products (Fig. 5B) . Because GFP is highly resistant to proteases [41] , the GFP itself maintained its antigenicity, whereas the equatorin portion of the EGFP-tagged equatorin protein was degraded, eliminating the MN9 antigenicity.
Based on the results in Figures 4 and 5B, we hypothesized that O-glycosylation at amino acid residues 101-146 was involved in the MN9 epitope. Because two serine and three threonine residues were not detected by LC-MS/MS in this region (Fig. 2) , we analyzed serine and threonine single amino acid substitution mutant proteins by Western blot (Fig. 5C) . The MN9 antibody detected all mutant proteins except the T138A mutant. This suggested that posttranslational modification occurs on threonine 138 and that this modification is involved in the MN9 epitope region.
Immunogold Electron Microscopy
Finally, we identified the localization of equatorin by immunogold electron microscopy using the MN9 antibody (Fig. 6) . Equatorin was enriched on the inner acrosomal membrane but minimal on the outer acrosomal membrane; this was typically seen in the anterior acrosome region (Fig. 6A) . In contrast, equatorin was enriched on both the inner and outer acrosomal membranes in the posterior acrosome region (equatorial segment) (Fig. 6B) . Immunogold particles were never observed on the plasma membrane in intact sperm (Fig.  6A) .
DISCUSSION
In the present study, we cloned the equatorin gene. We found it to encode a highly glycosylated protein, as shown in Figures 1-4 . First, we discuss the biochemical nature of equatorin. Because equatorin is a highly glycosylated sialoglycoprotein in mature sperm, it could not be detected by SYPRO Ruby (Fig.  1B, lanes 3 and 4) or silver staining (data not shown). By contrast, the equatorin band became detectable by Pro-Q Emerald 300 staining (Fig. 2, lane 6) , demonstrating sufficient staining intensity for its excision for LC-MS/MS. This lack of detection of equatorin using traditional protein staining protocols is attributable to the abundant carbohydrates, including sialic acid moieties, that interfere with the staining of glycoproteins in these protocols. In fact, desialylated equatorin was detected by silver staining (data not shown). Other glycoproteins also have been reported to show poor detectability with standard gel stains, such as silver stain and Coomassie Brilliant Blue staining, including flagellasialin [42] .
Based on sequence alignment analysis of equatorin homologues (Supplemental Fig. S2 ), the long form-specific region is highly conserved in mammals. Currently, no data are available to confirm that the long form is a precursor of the short form of equatorin. It is unclear why and how the long and short forms are present in the testis and which form is translated.
Our present results from the glycosylation study of equatorin (Fig. 4B) indicate that the asialylated form is estimated to be 27 kDa (Fig. 4B) , whereas the sialylated form is estimated to be at least 40 kDa (Fig. 1) . Considering that neuraminidase treatment reduced the relative molecular mass by roughly 13 kDa, equatorin is expected to be highly sialylated or polysialylated, although we cannot completely rule out the possibility that the reduction is because of protein cleavage induced by loss of stability [43, 44] or by intrinsic proteases activated by neuraminidase treatment.
With regard to the MN9 epitope, it is unlikely to contain Nlinked carbohydrate moieties, because the MN9 antibody still detected the equatorin molecule following PNGase F treatment (Fig. 4B) , which is known to release N-linked carbohydrates [45] . In addition, it also is unlikely that a neuraminic acid residue is essential for the MN9 epitope, because equatorin could be detected following neuraminidase treatment (Fig. 4B) . Neuraminidase from A. ureafaciens is known to release a2-(3,6,8)-linked neuraminic acid residues [46] . With regard to the possibility of phosphorylation, MN9 antigenicity of sperm EQUATORIN: IDENTIFICATION OF THE EPITOPE OF THE MN9 ANTIBODY equatorin remained even after CIAP treatment (Fig. 4A) , indicating that the MN9 epitope is not phosphorylated. Regarding the possibility of O-glycosylation, the MN9 epitope was sensitive to the O-glycosylation inhibitor Benzyl-aGalNAc (Fig. 4C) , suggesting that O-glycosylation is involved in the MN9 epitope. In addition, the finding that MN9 antibody detectability was lost by the substitution of threonine 138 to alanine (Fig. 5C) indicates the MN9 epitope region is localized around threonine 138. Taken together, these data strongly suggest either that the MN9 epitope contains an O-glycosylation around threonine 138 or that the modification is at least necessary for the equatorin conformation the MN9 antibody can recognize. It is noteworthy that the threonine corresponding to threonine 138 of mouse equatorin is well conserved in many mammals, including humans (Supplemental Fig. S3 ). In this context, further analyses are required to reveal the structure around threonine 138, including the glycan structure.
With regard to the domain of equatorin responsible for sperm-egg interaction, the anti-EQ 70-83 peptide antibody did not inhibit sperm-egg interaction (data not shown). This suggests the importance of the MN9 epitope domain around threonine 138.
The results derived from the EGFP-tagged equatorin study in HEK293T cells (Fig. 5 ) and immunogold staining analysis (Fig. 6) indicate that equatorin is predominantly present in the inner acrosome membrane, with the N-terminus facing the acrosomal lumen, as shown in our scheme (Fig. 7) . Before the acrosome reaction, equatorin was never found on the sperm plasma membrane, as previously reported [11, 12, 23] . During the acrosome reaction, some equatorin was released from the acrosome and reached the plasma membrane over the equatorial segment, where sperm-egg fusion takes place [11, 12, 23] . To our knowledge, no reports have shown the detailed orientation of the acrosomal transmembrane protein that is translocated during the acrosome reaction. Some acrosomal proteins, such as Izumo1 and SPACA4, also have been reported to translocate to the sperm cell surface, but the details of the translocation mechanism are unclear. Thus, several questions remain open, including how these translocating molecules detach from the acrosome and reattach to the cell membrane or, alternatively, whether they can move along the membrane. Information about the molecular structure and the defined epitopes of the antibodies will be useful to further analyze the translocation mechanism.
In summary, equatorin is a 40-to 50-kDa type 1 transmembrane N,O-sialoglycoprotein composed of a putative signal peptide region in the N-terminal 20 amino acids and a transmembrane region at residues 186-208. The gamete interaction-inhibiting epitope recognized by the MN9 antibody requires posttranslational modification, most likely O-glycosylation on threonine 138. The evidence accumulated thus far suggests that the N-terminal side of equatorin bears the MN9 epitope and faces the acrosomal lumen (Fig. 7) . During the acrosome reaction, some equatorin on the acrosomal membranes translocates onto the surface of the plasma membrane over the equatorial segment, and equatorin on the inner acrosomal membrane becomes exposed. The domain of equatorin around threonine 138 that reaches the equatorial segment is thought to play a role in sperm-egg interaction.
